Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GLAXF) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Gsk (GLAXF) over the last 17 years, with Q2 2025 value amounting to 0.02.

  • Gsk's Equity Ratio changed N/A to 0.02 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.02, marking a year-over-year change of. This contributed to the annual value of 0.22 for FY2024, which is 271.07% down from last year.
  • According to the latest figures from Q2 2025, Gsk's Equity Ratio is 0.02.
  • Gsk's 5-year Equity Ratio high stood at 0.23 for Q4 2023, and its period low was 0.02 during Q1 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.19 (2021), whereas its average is 0.15.
  • Per our database at Business Quant, Gsk's Equity Ratio plummeted by 741.74% in 2022 and then skyrocketed by 2837.42% in 2023.
  • Quarter analysis of 5 years shows Gsk's Equity Ratio stood at 0.19 in 2021, then dropped by 7.42% to 0.18 in 2022, then grew by 28.37% to 0.23 in 2023, then dropped by 2.71% to 0.22 in 2024, then crashed by 89.66% to 0.02 in 2025.
  • Its last three reported values are 0.02 in Q2 2025, 0.22 for Q4 2024, and 0.23 during Q4 2023.